Latest

SELLAS Life Sciences Announces Positive Pivotal Phase 3 REGAL Trial Data Showing Immunotherapeutic Cancer Vaccine, Galinpepimut-S (GPS), Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with Acute Myeloid Leukemia

Wednesday, 18 Nov 2026 8:32AM

- REGAL trial met its primary endpoint with GPS demonstrating statistically significant and clinical...

See More
H2O.ai Tops the Generative Pre-Trained Model Era of Predictive AI, Powered by Leading Foundation Models for Time-Series and Tabular Data

Wednesday, 18 Nov 2026 8:28AM

Led by the top-ranked time-series model (TimeH2O), it delivers accurate predictions without building...

See More

Other Press Release